InSilico Medicine Cayman TopCo (HKG:3696)

HKG:3696 Revenue

In the year 2025, InSilico Medicine Cayman TopCo had annual revenue of $56.24M USD, down -34.48%. InSilico Medicine Cayman TopCo had revenue of $28.78M in the half year ending December 31, 2025.

• Revenue: $56.24M
• Revenue Growth: -34.48%
• P/S Ratio: 51.55
• Revenue / Employee: $177.41K
• Employees: 317
• Market Cap: 22.56B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	56.24M	-29.60M	-34.48%
Dec 31, 2024	85.83M	34.65M	67.71%
Dec 31, 2023	51.18M	21.03M	69.77%
Dec 31, 2022	30.15M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error